495018
1-(叔丁氧基羰基)-3-哌啶甲酸
98%
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C11H19NO4
化学文摘社编号:
分子量:
229.27
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352200
MDL number:
产品名称
1-(叔丁氧基羰基)-3-哌啶甲酸, 98%
InChI
1S/C11H19NO4/c1-11(2,3)16-10(15)12-6-4-5-8(7-12)9(13)14/h8H,4-7H2,1-3H3,(H,13,14)
SMILES string
CC(C)(C)OC(=O)N1CCCC(C1)C(O)=O
InChI key
NXILIHONWRXHFA-UHFFFAOYSA-N
assay
98%
reaction suitability
reaction type: solution phase peptide synthesis
mp
159-162 °C (lit.)
application(s)
peptide synthesis
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
法规信息
新产品
此项目有
Bunta Watanabe et al.
PloS one, 10(8), e0136242-e0136242 (2015-08-22)
CCG-1423 suppresses several pathological processes including cancer cell migration, tissue fibrosis, and the development of atherosclerotic lesions. These suppressions are caused by inhibition of myocardin-related transcription factor A (MRTF-A), which is a critical factor for epithelial-mesenchymal transition (EMT). CCG-1423 can
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持